Last update :
01/07/2022
Analgesic   Parecoxib sodium  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Bextra Brazil
Dynastat Australia, Austria, Belgium, Denmark, Finland, France, Germany, Great Britain, Greece, Hungary, Iceland, Ireland, Italy, Japan, Luxembourg, Malaysia, Mexico, Netherlands, New Zealand, Norway, Peru, Poland, Portugal, Romania, Spain, Sweden, Switzerland, United Arab Emirates, United States of America, Venezuela
Parecoxib BPH Chile
Pro-Bextra Chile
Rayzon Ireland, Netherlands, Sweden
Valdyne Colombia
Valsafe India
Valto P India
Valus P India
Xapit Ireland, Netherlands
Stability in solutions   Injection   Stability in solutions : Parecoxib sodium     
Container Solvent Concentration Temperature Storage Length of time References
Glass Sodium chloride 0,9% 16 & 20 mg/ml 25°C Light
48 Hour
1824

Glass Sodium chloride 0,9% 16 & 20 mg/ml 5°C Protect from light
48 Hour
1824

Glass Glucose 5% 16 & 20 mg/ml 25°C Light
48 Hour
1824

Glass Glucose 5% 16 & 20 mg/ml 5°C Protect from light
48 Hour
1824

Glass NaCl 0,9% + antibacterial 16 & 20 mg/ml 25°C Light
48 Hour
1824

Glass NaCl 0,9% + antibacterial 16 & 20 mg/ml 5°C Protect from light
48 Hour
1824

Polypropylen Syringe Sodium chloride 0,9% 13,3 & 20 mg/ml 25°C Light
48 Hour
1824

Polypropylen Syringe Sodium chloride 0,9% 13,3 & 20 mg/ml 5°C Protect from light
48 Hour
1824

Polypropylen Syringe Glucose 5% 13,3 & 20 mg/ml 25°C Light
48 Hour
1824

Polypropylen Syringe Glucose 5% 13,3 & 20 mg/ml 5°C Protect from light
48 Hour
1824

Polypropylen Syringe NaCl 0,9% + antibacterial 13,3 & 20 mg/ml 25°C Light
48 Hour
1824

Polypropylen Syringe NaCl 0,9% + antibacterial 13,3 & 20 mg/ml 5°C Protect from light
48 Hour
1824


  Mentions Légales